-
Signature
-
/s/ Remie Solano, Attorney-in-Fact
-
Issuer symbol
-
CRWD
-
Transactions as of
-
26 Nov 2021
-
Transactions value $
-
-$1,160,753
-
Form type
-
4
-
Filing time
-
30 Nov 2021, 15:07:10 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
CRWD |
Class A common stock |
Conversion of derivative security |
|
+5,000 |
|
|
5,000 |
26 Nov 2021 |
By Clavius Capital LLC |
F1, F2 |
| transaction |
CRWD |
Class A common stock |
Sale |
-$138,420 |
-600 |
-12% |
$230.7 |
4,400 |
26 Nov 2021 |
By Clavius Capital LLC |
F2, F3 |
| transaction |
CRWD |
Class A common stock |
Sale |
-$590,216 |
-2,547 |
-58% |
$231.73 |
1,853 |
26 Nov 2021 |
By Clavius Capital LLC |
F2, F4 |
| transaction |
CRWD |
Class A common stock |
Sale |
-$363,246 |
-1,560 |
-84% |
$232.85 |
293 |
26 Nov 2021 |
By Clavius Capital LLC |
F2, F5 |
| transaction |
CRWD |
Class A common stock |
Sale |
-$23,373 |
-100 |
-34% |
$233.73 |
193 |
26 Nov 2021 |
By Clavius Capital LLC |
F2 |
| transaction |
CRWD |
Class A common stock |
Sale |
-$45,497 |
-193 |
-100% |
$235.74 |
0 |
26 Nov 2021 |
By Clavius Capital LLC |
F2 |
| holding |
CRWD |
Class A common stock |
|
|
|
|
|
2,580 |
26 Nov 2021 |
Direct |
F6 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
CRWD |
Class B common stock |
Conversion of derivative security |
$0 |
-5,000 |
-5.6% |
$0 |
85,000 |
26 Nov 2021 |
Class A common stock |
5,000 |
$0 |
By Clavius Capital LLC |
F2, F7 |
| holding |
CRWD |
Class B common stock |
|
|
|
|
|
100,000 |
26 Nov 2021 |
Class A common stock |
100,000 |
$0 |
By Clavius AP, LLC |
F2, F7 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
All transactions were executed pursuant to a Rule 10b5-1 plan entered into by the Reporting Person.